News
Zacks.com on MSN16h
Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback